USPTO serial 79297555
Reviewed by CopyMark Law Group
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
DE
Other trademarks owned by Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
DE
Other trademarks owned by Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
DE
Other trademarks owned by Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
| Class | Description | Status | First use |
|---|---|---|---|
| 009 | Scientific apparatus and instruments, namely, laboratory apparatus and instruments for analyzing highly diluted fluorescence signals in nucleic acid solutions, micelle solutions, plasmid solutions or protein solutions; scientific apparatus and instruments, namely, electronic and optical apparatus in form of a plate reader, for analysis of highly diluted fluorescence signals in nucleic acid solutions, micelle solutions, plasmid solutions or protein solutions; testing apparatus not for medical purposes for analyzing the concentration, size and molarity of fluorescently labeled or fluorescent molecules, in particular labeled nucleic acids; downloadable and recorded computer software for live view of measurements in nucleic acid solutions, micelle solutions, plasmid solutions or protein solutions in the form of fluorescence traces and correlation curves, result presentation per sample, and save/load capabilities for measurements; parts of the aforesaid goods, namely, sample holders for laboratory apparatus and instruments for analyzing highly diluted fluorescence signals in nucleic acid solutions, micelle solutions, plasmid solutions or protein solutions | ACTIVE | — |
| 010 | Analysis devices and diagnostic apparatus for medical purposes, namely, medical apparatus for high-precision nucleic acid analysis for biomarker detection in the field of oncology or immunology and for sequence specific detection of viral components in the field of point-of-care or laboratory diagnosis; parts for all the aforesaid goods, namely, disposable probe holders for medical apparatus for high-precision nucleic acid analysis for biomarker detection in the field of oncology or immunology and for sequence specific detection of viral components in the context of point-of-care or laboratory diagnosis | ACTIVE | — |
| 041 | Organisation, arranging and conducting of courses, seminars, workshops, symposiums, con-gresses and conferences in the field of biotechnology, molecular biology, cell biology, mi-crobiology, immunology, genetics and medical research; Organisation, arranging and con-ducting of courses, seminars and workshops, in the field of training for handling scientific instruments and apparatus for research in laboratories | ACTIVE | — |
| 042 | Scientific and technological services, namely, research and design in the field of biotechnology, molecular biology, cell biology, microbiology, immunology and genetics; scientific and industrial research in the field of biotechnology, molecular biology, cell biology, microbiology, immunology and genetics; Testing, authentication and quality control for others, namely, testing of fluorescently labeled molecules or fluorescent molecules in terms of concentration, size and molarity; Testing, authentication and quality control for others, namely, testing of fluorescently labeled molecules or fluorescent molecules in terms of concentration, size and molarity in the field of health services, food and drink industry and chemical industry; development of measuring and testing methods for biology laboratory procedures; Technical measurement and analysis, namely, analysis of concentration, size and molarity of fluorescently labeled or fluorescent molecules, in particular labeled nucleic acids; Design and development of computer software; Medical laboratory services | ACTIVE | — |
| 044 | Conducting medical and clinical medical practice examinations | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 6, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Jan 17, 2023 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Jan 17, 2023 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Dec 27, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 27, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Sep 27, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 18, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 12, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 12, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 23, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 22, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 22, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 4, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 2, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 1, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 1, 2022 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 3, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 11, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 6, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 14, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 14, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 14, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 16, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 19, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 18, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 18, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 18, 2021 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Aug 18, 2021 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Aug 18, 2021 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Aug 18, 2021 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 18, 2021 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Aug 18, 2021 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Mar 15, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 24, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 24, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 19, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 18, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 11, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 13, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 9, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 5, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |